Concepedia

Lipid profiling of pre-treatment plasma reveals biomarker candidates associated with response rates and hand–foot skin reactions in sorafenib-treated patients

Kosuke Saito, Masafumi Ikeda, Yasushi Kojima, Hiroko Hosoi, Yoshiro Saito, Shunsuke Kondo

Cancer Chemotherapy and Pharmacology · 2018 · 24 citations · 30 references

Concepts

MedicineDermatologyPharmacologyCutaneous OncologyInflammationLipid BiochemistryBiomarker DevelopmentDrug-induced Skin ReactionsInflammatory BiomarkersLipidomicsPharmacogenomic BiomarkersClinical LipidomicsDrug-induced Hand-foot SyndromeHand-foot Skin ReactionInflammatory Skin ResponsesLipid Biomarker DiscoveryLipid ProfilingSkin Sensitivity ReactionsSorafenib Therapy

References

30

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro et al. · New England Journal of Medicine · 2008 · 13K citations · Full text

Medicine, Oncology, Pharmacology +12

Sorafenib in Advanced Hepatocellular Carcinoma

재연 정 · 2008 · 5.6K citations

Medicine, Oncology, Pharmacology +12

Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

Bernard Escudier, Tim Eisen, Walter M. Stadler et al. · New England Journal of Medicine · 2007 · 4.8K citations · Full text

Medicine, Nephrology, Oncology +11

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

Marcia S. Brose, Christopher M. Nutting, Barbara Jarząb et al. · The Lancet · 2014 · 1.6K citations · Full text

Medicine, Endocrinology, Oncology +11

Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5

Li Liu, Yichen Cao, Charles Chen et al. · Cancer Research · 2006 · 1.5K citations · Full text

Medicine, Oncology, Pharmacology +17